Product Details for: Ebglyss
RETURN TO SEARCH RESULTS
PRODUCT LABEL
Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Subcutaneous
250MG/2ML
Autoinjector
351(a)
Ebglyss
Rx
002
Injection
Subcutaneous
250MG/2ML
Pre-Filled Syringe
351(a)
Ebglyss
Rx
Proper Name
lebrikizumab-lbkz
lebrikizumab-lbkz
BLA Number
761306
761306
Applicant
Eli Lilly and Company
Eli Lilly and Company
Original Approval Date
September 13, 2024
September 13, 2024
Date of First Licensure